IKIDS study receives new funding to explore how environmental exposures influence child health

Seven years after an initial $17.9 million award from the National Institutes of Health, the Illinois Kids Development Study at the University of Illinois Urbana-Champaign will receive approximately $13.7 million – awarded in two phases – to continue its work for another seven years.

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called

July 27, 2023

Novel Image Analysis IDs Women for MRI After Negative Mammography

An artificial intelligence tool to select individuals for supplemental MRI scans after negative mammography led to detection of many cancers that would otherwise have been

July 10, 2024

ViiV’s long-acting HIV injectable Cabenuva preferred over Biktarvy by 90% of patients in PhIII trial

Most HIV patients in a Phase III study investigating ViiV Healthcare’s long-acting injectable Cabenuva and Gilead Sciences’ daily pill Biktarvy preferred the injection over the

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.